This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Sep 17;383(12):1193-1194.

doi: 10.1056/NEJMc2023284.

Liraglutide for Adolescents with Obesity. Reply

Aaron S Kelly¹, Paula M Hale²

Affiliations

PMID: 32937058
DOI: 10.1056/NEJMc2023284

Comment

Liraglutide for Adolescents with Obesity. Reply

Aaron S Kelly et al. N Engl J Med. 2020.

. 2020 Sep 17;383(12):1193-1194.

doi: 10.1056/NEJMc2023284.

Authors

Aaron S Kelly¹, Paula M Hale²

Affiliations

¹ University of Minnesota Medical School, Minneapolis, MN.
² Novo Nordisk, Plainsboro, NJ.

PMID: 32937058
DOI: 10.1056/NEJMc2023284

No abstract available

PubMed Disclaimer

Comment on

Liraglutide for Adolescents with Obesity.
Anker MS, Butler J, Anker SD. Anker MS, et al. N Engl J Med. 2020 Sep 17;383(12):1192. doi: 10.1056/NEJMc2023284. N Engl J Med. 2020. PMID: 32937055 No abstract available.
Liraglutide for Adolescents with Obesity.
Amarin JZ, Dahbour AS, Zayed AA. Amarin JZ, et al. N Engl J Med. 2020 Sep 17;383(12):1193. doi: 10.1056/NEJMc2023284. N Engl J Med. 2020. PMID: 32937056 No abstract available.
Liraglutide for Adolescents with Obesity.
Maljaei MB, Bahreini A. Maljaei MB, et al. N Engl J Med. 2020 Sep 17;383(12):1193. doi: 10.1056/NEJMc2023284. N Engl J Med. 2020. PMID: 32937057 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information